Literature DB >> 11356201

Analysis of N-glycans of pathological tau: possible occurrence of aberrant processing of tau in Alzheimer's disease.

Y Sato1, Y Naito, I Grundke-Iqbal, K Iqbal, T Endo.   

Abstract

In a previous study [Wang et al. (1996) Nat. Med. 2, 871-875], Wang et al. found (i) that abnormally hyperphosphorylated tau (AD P-tau) isolated from Alzheimer's disease (AD) brain as paired helical filaments (PHF)-tau and as cytosolic AD P-tau but not tau from normal brain were stained by lectins, and (ii) that on in vitro deglycosylation the PHF untwisted into sheets of thin straight filaments, suggesting that tau only in AD brains is glycosylated. To elucidate the primary structure of N-glycans, we comparatively analyzed the N-glycan structures obtained from PHF-tau and AD P-tau. More than half of N-glycans found in PHF-tau and AD P-tau were different. High mannose-type sugar chains and truncated N-glycans were found in both taus in addition to a small amount of sialylated bi- and triantennary sugar chains. More truncated glycans were richer in PHF-tau than AD P-tau. This enrichment of more truncated glycans in PHF might be involved in promoting the assembly and or stabilizing the pathological fibrils in AD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356201     DOI: 10.1016/s0014-5793(01)02421-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.

Authors:  Niklas Reich; Christian Hölscher
Journal:  Front Neurosci       Date:  2022-09-01       Impact factor: 5.152

Review 2.  Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.

Authors:  Hussein Abou-Abbass; Hadi Abou-El-Hassan; Hisham Bahmad; Kazem Zibara; Abir Zebian; Rabab Youssef; Joy Ismail; Rui Zhu; Shiyue Zhou; Xue Dong; Mayse Nasser; Marwan Bahmad; Hala Darwish; Yehia Mechref; Firas Kobeissy
Journal:  Electrophoresis       Date:  2016-04-04       Impact factor: 3.535

3.  Involvement of Maillard reactions in Alzheimer disease.

Authors:  V Prakash Reddy; Mark E Obrenovich; Craig S Atwood; George Perry; Mark A Smith
Journal:  Neurotox Res       Date:  2002-05       Impact factor: 3.911

Review 4.  The dynamic brain N-glycome.

Authors:  Thomas S Klarić; Gordan Lauc
Journal:  Glycoconj J       Date:  2022-03-25       Impact factor: 2.916

Review 5.  The Role of Post-Translational Modifications on the Structure and Function of Tau Protein.

Authors:  Haiqiong Ye; Yue Han; Ping Li; Zhengding Su; Yongqi Huang
Journal:  J Mol Neurosci       Date:  2022-03-24       Impact factor: 2.866

6.  LW-AFC Effects on N-glycan Profile in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.

Authors:  Jianhui Wang; Xiaorui Cheng; Ju Zeng; Jiangbei Yuan; Zhongfu Wang; Wenxia Zhou; Yongxiang Zhang
Journal:  Aging Dis       Date:  2017-02-01       Impact factor: 6.745

Review 7.  Early Stage Glycosylation Biomarkers in Alzheimer's Disease.

Authors:  Patricia Regan; Paula L McClean; Thomas Smyth; Margaret Doherty
Journal:  Medicines (Basel)       Date:  2019-09-03

8.  Novel model of secreted human tau protein reveals the impact of the abnormal N-glycosylation of tau on its aggregation propensity.

Authors:  Yelena Losev; Ashim Paul; Moran Frenkel-Pinter; Malak Abu-Hussein; Isam Khalaila; Ehud Gazit; Daniel Segal
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

9.  Lithium induces ER stress and N-glycan modification in galactose-grown Jurkat cells.

Authors:  Tamás Nagy; Dorottya Frank; Emese Kátai; Rikki K K Yahiro; Viktor S Poór; Gergely Montskó; Zita Zrínyi; Gábor L Kovács; Attila Miseta
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

10.  Minimotifs dysfunction is pervasive in neurodegenerative disorders.

Authors:  Surbhi Sharma; Richard J Young; Jingchun Chen; Xiangning Chen; Edwin C Oh; Martin R Schiller
Journal:  Alzheimers Dement (N Y)       Date:  2018-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.